Synthesis, Design, and Structure–Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase
Open Access
Abstract
The inhibition of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) potentially represents a new treatment option for malaria, as P. falciparum relies entirely on a de novo pyrimidine biosynthetic pathway for survival. Herein, we report a series of pyrimidone derivatives as novel inhibitors of PfDHODH. The most potent compound, 26, showed high inhibition activity against PfDHODH (IC50 = 23 nM), with >400-fold species selectivity over human dihydroorotate dehydrogenase (hDHODH). The brand-new inhibitor scaffold targeting PfDHODH reported in this work may lead to the discovery of new antimalarial agents.Keywords
This publication has 38 references indexed in Scilit:
- Towards real-time monitoring of artemisinin resistanceThe Lancet Infectious Diseases, 2015
- Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistanceScience, 2015
- Genetic architecture of artemisinin-resistant Plasmodium falciparumNature Genetics, 2015
- Antimalarials in Development in 2014Chemical Reviews, 2014
- MalariaThe Lancet, 2014
- Malaria biology and disease pathogenesis: insights for new treatmentsNature Medicine, 2013
- Artemisinin resistance: current status and scenarios for containmentNature Reviews Microbiology, 2010
- Defining the role of PfCRT in Plasmodium falciparum chloroquine resistanceMolecular Microbiology, 2005
- Mechanisms of resistance of Plasmodium falciparum to antimalarial drugsMicrobes and Infection, 2002
- Rational Drug Design Approach for Overcoming Drug Resistance: Application to Pyrimethamine Resistance in MalariaJournal of Medicinal Chemistry, 1998